CASE AND COMMENTARY: PEER-REVIEWED ARTICLE Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units?

Alex Rollo; Jeena Kar; Uma Suryadevara; Mary Camp

doi:10.1001/amajethics.2023.725

CASE AND COMMENTARY: PEER-REVIEWED ARTICLE Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units?

Alex Rollo, Jeena Kar, Uma Suryadevara, Mary Camp

Research output: Contribution to journal › Review article › peer-review

Abstract

This commentary on a case considers risks and benefits of pharmacological and nonpharmacological management of agitation in patients with dementia. Specifically, it considers beneficence and nonmaleficence in treatment decisions that affect both patients and staff as well as autonomy and surrogate decision making.

Original language	English (US)
Pages (from-to)	E725-E732
Journal	AMA journal of ethics
Volume	25
Issue number	10
DOIs	https://doi.org/10.1001/amajethics.2023.725
State	Published - Oct 1 2023

ASJC Scopus subject areas

Issues, ethics and legal aspects
Health(social science)
Health Policy

Access to Document

10.1001/amajethics.2023.725

Fingerprint

Dive into the research topics of 'CASE AND COMMENTARY: PEER-REVIEWED ARTICLE Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units?'. Together they form a unique fingerprint.

Cite this

CASE AND COMMENTARY: PEER-REVIEWED ARTICLE Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? / Rollo, Alex; Kar, Jeena; Suryadevara, Uma et al.
In: AMA journal of ethics, Vol. 25, No. 10, 01.10.2023, p. E725-E732.

Research output: Contribution to journal › Review article › peer-review

@article{05a47313437949e19166b40768425e16,

title = "CASE AND COMMENTARY: PEER-REVIEWED ARTICLE Should Antipsychotics{\textquoteright} Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults{\textquoteright} Behavioral Symptoms in Short-Staffed Units?",

abstract = "This commentary on a case considers risks and benefits of pharmacological and nonpharmacological management of agitation in patients with dementia. Specifically, it considers beneficence and nonmaleficence in treatment decisions that affect both patients and staff as well as autonomy and surrogate decision making.",

author = "Alex Rollo and Jeena Kar and Uma Suryadevara and Mary Camp",

year = "2023",

month = oct,

day = "1",

doi = "10.1001/amajethics.2023.725",

language = "English (US)",

volume = "25",

pages = "E725--E732",

journal = "AMA journal of ethics",

issn = "2376-6980",

publisher = "American Medical Association",

number = "10",

}

TY - JOUR

T1 - CASE AND COMMENTARY

T2 - PEER-REVIEWED ARTICLE Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units?

AU - Rollo, Alex

AU - Kar, Jeena

AU - Suryadevara, Uma

AU - Camp, Mary

PY - 2023/10/1

Y1 - 2023/10/1

N2 - This commentary on a case considers risks and benefits of pharmacological and nonpharmacological management of agitation in patients with dementia. Specifically, it considers beneficence and nonmaleficence in treatment decisions that affect both patients and staff as well as autonomy and surrogate decision making.

AB - This commentary on a case considers risks and benefits of pharmacological and nonpharmacological management of agitation in patients with dementia. Specifically, it considers beneficence and nonmaleficence in treatment decisions that affect both patients and staff as well as autonomy and surrogate decision making.

UR - http://www.scopus.com/inward/record.url?scp=85175585527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85175585527&partnerID=8YFLogxK

U2 - 10.1001/amajethics.2023.725

DO - 10.1001/amajethics.2023.725

M3 - Review article

C2 - 37801055

AN - SCOPUS:85175585527

SN - 2376-6980

VL - 25

SP - E725-E732

JO - AMA journal of ethics

JF - AMA journal of ethics

IS - 10

ER -

CASE AND COMMENTARY: PEER-REVIEWED ARTICLE Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this